Trial Will Test New Combination Regimen for Stem Cell Collection

Trial Will Test New Combination Regimen for Stem Cell Collection

284209

Trial Will Test New Combination Regimen for Stem Cell Collection

A clinical trial will assess a combination of MGTA-145 plus plerixafor as a new regimen for aiding in the collection of blood stem cells from adults and adolescents with sickle cell disease (SCD). The proof-of-concept trial, a collaboration between Magenta Therapeutics and Bluebird Bio, may establish this new combination as a better mobilization regimen for these patients. Such a much-needed regimen would provide an important alternative for people with SCD who cannot use more common…

You must be logged in to read/download the full post.